Tirofiban Plus Sirolimus-Eluting Stent May Offer Better Outcome After Acute STEMI Than Bare-Metal Stent Plus Abciximab

The investigators in a randomized trial suggest that tirofiban-supported sirolimus-eluting stenting of infarcted arteries may improve outcomes and limit healthcare costs. (CME)Desiree Lie,Laurie Barclay,Gary Vogin

Continue to Tirofiban Plus Sirolimus-Eluting Stent May Offer Better Outcome After Acute STEMI Than Bare-Metal Stent Plus Abciximab on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz